Back

Watch Compare

ACCENDRA HEALTH INC/VA/

Data quality: 83%

ACH

NYSE Wholesale Trade Durable Goods Wholesale

$2.66

▲ $0.09 (3.31%)

Mkt Cap: 202.94 M

Price

$2.66

Mkt Cap

202.94 M

Day Range

$2.55 — $2.67

52-Week Range

$1.84 — $9.55

Volume

343,842

Open $2.54

50D / 200D Avg

$2.32

14.62% above

50D / 200D Avg

$4.24

37.38% below

Quick Summary

Key Takeaways

Revenue declined -27.11% annually over 5 years

Revenue growth is decelerating — 1Y growth trails 5Y average by 47.08%

Capital efficient — spends only 6.91% of revenue on capex

ROIC of 1.42% — low return on invested capital

Interest coverage of 0.26× — tight debt servicing

Growth

Revenue Growth (5Y)

-27.11%

Below sector avg (2.60%)

Revenue (1Y)-74.19%

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

N/A

ROIC1.42%

Net Margin-39.85%

Op. Margin0.99%

Safety

Debt / Equity

N/A

Current Ratio0.86

Interest Coverage0.26

Valuation

PE (TTM)

-0.18

Below sector avg (-0.15)

P/B RatioN/A

EV/EBITDA0.70

Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Wholesale Trade sector median (91 peers)

Metric	Stock	Sector Median
P/E	-0.2	-0.2
P/B	—	1.0
ROE %	—	-3.2
Net Margin %	-39.9	-2.2
Rev Growth 5Y %	-27.1	2.6
D/E	—	0.3

All Fundamental Metrics

Growth
Revenue Growth (1Y)	-74.19%	Revenue Growth (3Y)	-48.30%
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	-27.11%	Earnings Growth (5Y)	N/A
Profitability
Revenue (TTM)	2.76 B	Net Income (TTM)	-1.10 B
ROE	N/A	ROA	-26.88%
Gross Margin	N/A	Operating Margin	0.99%
Net Margin	-39.85%	Free Cash Flow (TTM)	N/A
ROIC	1.42%	FCF Growth (3Y)	N/A
Safety
Debt / Equity	N/A	Current Ratio	0.86
Interest Coverage	0.26	Asset Turnover	0.67
Working Capital	-334.29 M	Tangible Book Value	-1.82 B
Dividends
Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A
Valuation
P/E Ratio	-0.18	Forward P/E	N/A
P/B Ratio	N/A	P/S Ratio	0.07
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	0.70	Fwd EV/EBITDA	N/A
Forward P/S	N/A	Fwd Earnings Yield	N/A
FCF Yield	N/A
Market Cap	202.94 M	Enterprise Value	170.11 M
Per Share
EPS (Diluted TTM)	-14.31	Revenue / Share	36.13
FCF / Share	N/A	OCF / Share	N/A
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A
Efficiency
CapEx / Revenue	6.91%	FCF Conversion	N/A
SBC-Adj. FCF	N/A	Growth Momentum	-47.08

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	2.76 B	10.70 B	10.33 B	9.96 B	9.79 B
Net Income	-1.10 B	-362.69 M	-41.30 M	22.39 M	221.59 M
EPS (Diluted)	-14.31	-4.73	-0.54	0.29	2.94
Gross Profit	—	2.22 B	2.13 B	1.83 B	1.51 B
Operating Income	27.46 M	-207.77 M	104.51 M	142.91 M	368.47 M
EBITDA	—	—	—	—	—
R&D Expenses	—	13.00 M	13.20 M	—	—
SG&A Expenses	1.07 B	1.91 B	1.81 B	1.63 B	1.12 B
D&A	214.52 M	264.78 M	287.38 M	228.67 M	90.62 M
Interest Expense	107.18 M	143.80 M	157.92 M	128.89 M	48.09 M
Income Tax	729,000.0	5.33 M	-13.43 M	-11.50 M	55.17 M

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	2.45 B	4.66 B	5.09 B	5.39 B	3.54 B
Total Liabilities	2.91 B	4.09 B	4.17 B	4.44 B	2.60 B
Shareholders' Equity	-460.98 M	565.23 M	924.17 M	945.60 M	938.50 M
Total Debt	—	—	—	—	—
Cash & Equivalents	281.99 M	49.38 M	243.04 M	69.47 M	55.71 M
Current Assets	547.87 M	2.02 B	2.10 B	2.30 B	2.32 B
Current Liabilities	947.08 M	1.87 B	1.89 B	1.57 B	1.34 B